Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

$4.3B

Market Cap • 12/26/2024

2014

(10 years)
Founded

2022

(2 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Redwood

Headquarters • California